The Clinical Efficacy of Switching Therapy Between Biological Agents and JAK Inhibitors in the Patients with Rheumatoid Arthritis

被引：0
|
作者：
Choshi, Tomokazu [1 ]
Mamoto, Kenji [1 ]
Yamada, Yutaro [1 ]
Okano, Tadashi [1 ]
Anno, Shohei [2 ]
Orita, Kazuki [2 ]
Iida, Takahiro [3 ]
Tada, Masahiro [4 ]
Inui, Kentaro [5 ]
Koike, Tatsuya [6 ]
Nakamura, Hiroaki [1 ]
机构：
[1] Osaka Metropolitan Univ, Osaka, Japan
[2] Yodogawa Christians Hosp, Osaka, Japan
[3] Koryokai Hosp, Osaka, Japan
[4] Osaka City Gen Hosp, Osaka, Japan
[5] Saiseikai Nakatsu Hosp, Osaka, Japan
[6] Shirahama Fdn Hlth & Welf, Search Inst Bone & Arthrit Dis SINBAD, Shirahama, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0426
引用
收藏
页码：826 / 827
页数：2
相关论文
共 50 条
  • [41] Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
    Marta Novella-Navarro
    Chamaida Plasencia
    Carolina Tornero
    Victoria Navarro-Compán
    José L. Cabrera-Alarcón
    Diana Peiteado-López
    Laura Nuño
    Irene Monjo-Henry
    Karen Franco-Gómez
    Alejandro Villalba
    Alejandro Balsa
    Arthritis Research & Therapy, 22
  • [42] Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlook
    Sonomoto, Koshiro
    Tanaka, Yoshiya
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (11) : 1325 - 1342
  • [43] Switching of biological therapies in Brazilian patients with rheumatoid arthritis
    de Lucena Valim, Juliana Miranda
    Goncalves Chaer, Fernanda Gomes
    Guimaraes da Silveira, Fernanda D'Oliveira
    da Silva e Lima, Veronica Palmiro
    Batista de Souza, Branca Dias
    FUTURE SCIENCE OA, 2019, 5 (01):
  • [44] Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors
    Atzeni, Fabiola
    Talotta, Rossella
    Nucera, Valeria
    Marino, Francesca
    Gerratana, Elisabetta
    Sangari, Donatella
    Masala, Ignazio Francesco
    Sarzi-Puttini, Piercarlo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 945 - 956
  • [45] Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
    Balsa, Alejandro
    Fontecha, Petra Diaz del Campo
    Fernandez, Lucia Silva
    Martin, Jose Valencia
    Martinez, Virginia Nistal
    Vazquez, Fernando Leon
    Hernandez, M. Vanesa Hernandez
    Corominas, Hector
    Caliz, Rafael Caliz
    Garcia, Jose Maria Aguado
    Rodriguez, Gloria Candelas
    Roteta, Nora Ibargoyen
    Carvajal, Arturo Marti
    Farras, M. Nieves Plana
    Rioboo, Janet Punal
    Park, Hye Sang
    Pego, Yolanda Trinanes
    Garcia, Virginia Villaverde
    REUMATOLOGIA CLINICA, 2023, 19 (10): : 533 - 548
  • [46] Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
    Meyer, Anja
    Wittekind, Paula S.
    Kotschenreuther, Konstantin
    Schiller, Joanna
    von Tresckow, Julia
    Haak, Thomas H.
    Kofler, David M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (12)
  • [47] Nationwide Retrospective Cohort Study on Clinical Outcomes in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
    Moret, Yurilu Gonzalez
    Lema, Diego
    Quinonez, Fabian Rodriguez
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2839 - 2841
  • [48] INFECTIONS AMONG RHEUMATOID ARTHRITIS PATIENTS STARTING OR SWITCHING BIOLOGICAL AGENTS: A SYSTEMATIC LITERATURE REVIEW
    Novella-Navarro, M.
    Gomez-Gomez, A.
    Cabrera-Alarcon, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S336 - S337
  • [49] The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
    Curtis, Jeffrey R.
    Xie, Fenglong
    Chen, Lang
    Baddley, John W.
    Beukelman, Timothy
    Saag, Kenneth G.
    Spettell, Claire
    McMahan, Raechele M.
    Fernandes, Joaquim
    Winthrop, Kevin
    Delzell, Elizabeth
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08) : 1401 - 1406
  • [50] Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
    Paul Emery
    Janet E. Pope
    Klaus Kruger
    Ralph Lippe
    Ryan DeMasi
    Sadiq Lula
    Blerina Kola
    Advances in Therapy, 2018, 35 : 1535 - 1563
12345